Annals of the Rheumatic Diseases
@ard.eular.org
ARD is the leading rheumatology journal and it is committed to promoting the highest standards of scientific exchange and education.
#EULAR2025 Pearls of wisdom from the difficult cases of #SLE #pregnancy 🤰🦋
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
June 14, 2025 at 12:14 PM
#EULAR2025 Pearls of wisdom from the difficult cases of #SLE #pregnancy 🤰🦋
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🎤 Ricardo J. O. Ferreira presented the HPR highlights during the closing plenary session of #EULAR2025.
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
June 14, 2025 at 12:02 PM
🎤 Ricardo J. O. Ferreira presented the HPR highlights during the closing plenary session of #EULAR2025.
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
Highlights #EULAR2025 from the PARE Sessions by Michael Poelzi :
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
June 14, 2025 at 11:44 AM
Highlights #EULAR2025 from the PARE Sessions by Michael Poelzi :
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🎯 At #EULAR2025, Rafael Prieto Moreno reminded us:
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
June 14, 2025 at 11:02 AM
🎯 At #EULAR2025, Rafael Prieto Moreno reminded us:
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
📊 At #EULAR2025, Loreto Carmona illustrated how social determinants shape RA outcomes in Spain — through the compelling case of a woman living with RA.
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
June 14, 2025 at 10:58 AM
📊 At #EULAR2025, Loreto Carmona illustrated how social determinants shape RA outcomes in Spain — through the compelling case of a woman living with RA.
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 14, 2025 at 10:54 AM
🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
After GRAPPA, it's time for EULAR to its points to consider and definitions of difficult-to-manage and treatment-refractory PsA
#EULAR2025
Posted by @jgletarouilly.bsky.social
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 14, 2025 at 10:33 AM
After GRAPPA, it's time for EULAR to its points to consider and definitions of difficult-to-manage and treatment-refractory PsA
#EULAR2025
Posted by @jgletarouilly.bsky.social
#EULAR2025
Posted by @jgletarouilly.bsky.social
Health literacy isn’t about “high” or “low”, it’s about challenges, needs, and diversity.
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
June 14, 2025 at 7:58 AM
Health literacy isn’t about “high” or “low”, it’s about challenges, needs, and diversity.
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
📚 Jet Veldhuijzen van Zanten presented the updated EULAR recommendations on patient education for people with inflammatory arthritis at #EULAR2025.
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
June 14, 2025 at 7:55 AM
📚 Jet Veldhuijzen van Zanten presented the updated EULAR recommendations on patient education for people with inflammatory arthritis at #EULAR2025.
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
🚺 #EULAR2025 RMD & #Menopause: is there a place for HRT? YES!
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
June 14, 2025 at 7:34 AM
🚺 #EULAR2025 RMD & #Menopause: is there a place for HRT? YES!
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
June 13, 2025 at 4:52 PM
🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 4:09 PM
📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🧠✨GRAPPA Definitions
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 3:47 PM
🧠✨GRAPPA Definitions
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
June 12, 2025 at 1:34 PM
Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
📢 Reminder at #EULAR2025
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
June 12, 2025 at 8:16 AM
📢 Reminder at #EULAR2025
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
June 12, 2025 at 7:35 AM
Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
June 12, 2025 at 7:06 AM
Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
🔬SPEED RCT in patients with PsA and poor prognostic factors
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 5:45 AM
🔬SPEED RCT in patients with PsA and poor prognostic factors
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
📍Foot OA affects 1 in 6 adults >50 and is often disabling.
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
June 11, 2025 at 3:29 PM
📍Foot OA affects 1 in 6 adults >50 and is often disabling.
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
Get ready for #EULAR2025!
✨️ Select from 177 Scientific sessions
✨️ Enjoy interaction with 350 distinguished speakers
✨️ Check out the new session formats
✅️ Spotlight consultation
✅️ Rheumatology meets ...
✅️ Fishbowl sessions
There is something for everyone!
@eular.org
✨️ Select from 177 Scientific sessions
✨️ Enjoy interaction with 350 distinguished speakers
✨️ Check out the new session formats
✅️ Spotlight consultation
✅️ Rheumatology meets ...
✅️ Fishbowl sessions
There is something for everyone!
@eular.org
June 11, 2025 at 9:22 AM
Get ready for #EULAR2025!
✨️ Select from 177 Scientific sessions
✨️ Enjoy interaction with 350 distinguished speakers
✨️ Check out the new session formats
✅️ Spotlight consultation
✅️ Rheumatology meets ...
✅️ Fishbowl sessions
There is something for everyone!
@eular.org
✨️ Select from 177 Scientific sessions
✨️ Enjoy interaction with 350 distinguished speakers
✨️ Check out the new session formats
✅️ Spotlight consultation
✅️ Rheumatology meets ...
✅️ Fishbowl sessions
There is something for everyone!
@eular.org
Good morning Barcelona! We are fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors.
👉🏻Follow along for live updates!
👉🏻Follow along for live updates!
June 11, 2025 at 8:54 AM
Good morning Barcelona! We are fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors.
👉🏻Follow along for live updates!
👉🏻Follow along for live updates!